Home > About > History
Our company first obtained the exclusive sales rights in 22 countries for the facial filler AestheFill® and body filler PowerFill® produced by Regen Biotech. Of these, approval has already been completed in 4 countries, and it’s in process in another 15 countries.
RegenBio Global was established in October 2015. And it was founded dreaming of the globalization of domestic medical devices.
02 Obtained CE approval
07 Completed registration in Chile for AestheFill and
PowerFill
09 Obtained approval in Georgia
02 Obtained Korea Design Patent
10 AestheFill Taiwan Launch
12 Obtained AestheFill ANVISA approval in Brazil
03 Obtained Russia Trademark
05 Obtained Swiss, Germany, France, England,
Ireland, Netherland, Spain, Italy, Turkey Patent:
Biodegradable polymeric microparticles and their
preparation method
12 Obtained Russia Trademark
03 For AestheFill and PowerFill, Thai FDA
distribution permit in Thailand obtained
03 Nico-N Clinical Test applied to KFDA
11 Obtained China Trademark
07 ISO 13485 Certification obtained
04 For AestheFill & PowerFill, KFDA manufacture
license obtained
06 AestheFill Exclusive Distribution Contracts with
partners in Singapore, Malaysia, Indonesia,
Philippines, India, Vietnam and Russia.
09 AestheFill Exclusive Distribution Contracts with
Senochem Biotech in China
12 For AestheFill & PowerFill, KFDA manufacture
license applied
09 Clinical Tests on AestheFill Completed at Asan
Medical Center and Chung-ang Univeristy
Hospital in Seoul
10 Clinical Tests on PowerFill Completed at Korea
University Guro Hospital and Hallym University
Medical Center in Seoul
01 Commercialized Birdie Shot, an Nico-N functional
beverage to release hang-over, and an
Nico-N candy
05 Completed Pre-clinical trials on MPLF for dermal
tissues
06 Marketed ATONATURAL, a Moisturizer for Perfect
Atopy Therapy
07 Developed 100% Atopy Natural Bioserum,
BioCellulose Sheet Pack and Atopy Nutritional
Supplement
08 The Third Phase of Original Technology
Development Business in progress (R&D of
Customized Porous Particles): Biocompatible,
Biodegradable, Cell- attractable for Tissue
Engineering & Regeneration,
Sept. 2003 to Mar. 2011
11 Validity of our medical device certified by KGMP (Certification renewed)
07 Selected as the Medium-sized Venture of
Technology Innovation by INNOBIZ
01 Negotiated with Japan, Thailand, Brazil, and India
for export contracts and license sharing
agreements on PowerPol
11 Validity of our medical device certified by Korea Good Manufacturing Practice (KGMP)
03 PowerPol approved by KFDA
09 REGEN project selected as the New Technology for Next Generation of the Ministry of Industry and Resources
07 REGEN project selected as the Venture of INNOBIZ by SMBA; Selected as the Co-Development of Core Technology Program of the former Ministry of Industry and Resources (current Ministry of Knowledge Economy)
10 The Best Venture Enterprise Award be conferred by the Special Committee on Medium Enterprises